Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,164,523
+$6,967,314 QoQ
Shares Held
270,457
+58.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#121
of 641 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. RPRX ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,164,523 | 270,457 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,197,209 | 170,882 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,875,682 | 203,822 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,744,384 | 49,444 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,458,759 | 68,242 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,813,877 | 347,378 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,622,981 | 142,022 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $3,754,337 | 132,709 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $254,285 | 9,643 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $862,052 | 28,385 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,158,523 | 112,443 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $544,726 | 20,071 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $627,649 | 20,418 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $770,393 | 21,382 | Shares | Sole | 2023-04-24 | |
| 2022-09-30 | $685,671 | 17,065 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $804,813 | 19,144 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $352,911 | 8,856 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,031,218 | 28,534 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,020,651 | 24,900 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,086,138 | 24,900 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,246,245 | 24,900 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||